发明名称 |
SUSTAINED-RELEASE DOSAGE FORMS FOR CABERGOLINE |
摘要 |
The present invention in one embodiment is directed to sustained-release dosage forms of cabergoline and other ergoline derivatives, which provide a zero-order or near zero-order release profile. The invention in another embodiment is directed to a method for treating Parkinson's disease, Progressive Supranuclear Palsy, Multisystemic Atrophy, Restless Legs Syndrome, Fibromyalgia, Chronic Fatigue Syndrome, stroke and nervous system disorders, including addictive disorders, using sustained-release dosage forms containing cabergoline or a pharmaceutically acceptable salts thereof. |
申请公布号 |
WO2005102272(A2) |
申请公布日期 |
2005.11.03 |
申请号 |
WO2005IB01010 |
申请日期 |
2005.04.11 |
申请人 |
PFIZER PRODUCTS INC.;MURPHY, THOMAS, K.;EISENHART, ERIC, K. |
发明人 |
MURPHY, THOMAS, K.;EISENHART, ERIC, K. |
分类号 |
A61K9/00;A61K9/16;A61K9/20;A61K9/28;A61K9/50 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|